Adam Houghton
Directeur/Membre du Conseil chez Kojin Therapeutics, Inc.
Profil
Currently, Adam Houghton is Vice President for AbbVie Ventures.
Lord Houghton is also on the board of Kojin Therapeutics, Inc.
He previously was Senior Research Scientist at Procter & Gamble Co. and Senior Director & Head-Search & Evaluation at Biogen Corp.
Ltd.
Adam Houghton received an MBA from Xavier University and an undergraduate degree from Yale University.
Postes actifs de Adam Houghton
Sociétés | Poste | Début |
---|---|---|
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Directeur/Membre du Conseil | - |
Anciens postes connus de Adam Houghton
Sociétés | Poste | Fin |
---|---|---|
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Private Equity Investor | 01/09/2021 |
Biogen Corp. Ltd. | Directeur-Opérations de Back Office | 28/02/2018 |
ELI LILLY AND COMPANY | Directeur/Membre du Conseil | 28/02/2015 |
PROCTER & GAMBLE COMPANY | Directeur Technique/Scientifique/R&D | 30/06/2005 |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Formation de Adam Houghton
Xavier University | Masters Business Admin |
Yale University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Entreprise privées | 4 |
---|---|
Biogen Corp. Ltd. | |
Quench Bio, Inc.
Quench Bio, Inc. BiotechnologyHealth Technology Quench Bio, Inc. develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases. The company was founded by Mark J. Tebbe, Mike Nolan, and Arturo Zychlinsky and is headquartered in Cambridge, MA. | Health Technology |
Kojin Therapeutics, Inc.
Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Health Technology |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Finance |